kabutan

Konoshima Chemical, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 10%, Highest in Three Terms, Dividend Revised Upward by 3 Yen

Wed Mar 11, 2026 2:30 pm JST Earnings

4026 Konoshima Chemical Co.,Ltd. 【J-GAAP】

Earnings Report

Konoshima Chemical Co.,Ltd. <4026> [TSE Std] announced its financial results in the afternoon session on March 11th (14:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending April 2026 (May 2025 to January 2026) expanded 1.81 billion yen, an increase 38.0% compared to the same period last year.

In addition, the full-year forecast for ordinary profit has been revised upward 9.5%, from the previous forecast of 2.10 billion yen to 2.30 billion yen (compared to 1.71 billion yen in the previous period), increasing the growth rate from 22.2% to 33.9%, reaches new record high for the first time in three terms.

Based on the full-year plan announced by the company after the upward revision, our estimate of the ordinary profit for the November to April period (second half) is expected to increase 21.2%, from the previous forecast of 0.94 billion yen to 1.14 billion yen (compared to 0.73 billion yen in the same period of the previous year), increasing the growth rate from 28.3% to 55.4%.

In light of the strong performance, the company has increased its planned annual dividend for the current fiscal year from the original plan of 46 yen to 49 yen (compared to 44 yen in the previous period).

In the most recent three-month period, from November to January (3Q), the ordinary profit increased 98.5% from the same period last year, reaching 0.65 billion yen. The operating profit margin significantly improved from 5.2% in the same period last year to 9.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
May - Jan, 2023 19,152 1,318 1,285 972 107.5 62.0 Mar 12, 2024 J-GAAP
May - Jan, 2024 20,642 1,369 1,312 1,037 114.5 76.4 Mar 12, 2025 J-GAAP
May - Jan, 2025 20,793 1,895 1,811 1,274 140.4 78.7 Mar 11, 2026 J-GAAP
YoY +0.7% +38.4% +38.0% +22.9% +22.6%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Nov - Apr, 2025 Prev 14,273 990 944 697 76.7 23 Dec 10, 2025 J-GAAP
Nov - Apr, 2025 New 13,873 1,190 1,144 797 87.7 26 Mar 11, 2026 J-GAAP
Revision Rate -2.8% +20.2% +21.2% +14.3% +14.3%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr, 2026 Prev 28,100 2,200 2,100 1,500 165.1 46 Jun 11, 2025 J-GAAP
Apr, 2026 New 27,700 2,400 2,300 1,600 176.1 49 Mar 11, 2026 J-GAAP
Revision Rate -1.4% +9.1% +9.5% +6.7% +6.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Nov - Apr, 2024 13,501 768 736 727 80.2 22 Jun 11, 2025 J-GAAP
Nov - Apr, 2025 Guidance 13,873 1,190 1,144 797 87.7 26 Mar 11, 2026 J-GAAP
YoY +2.8% +54.9% +55.4% +9.6% +9.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr, 2024 25,974 2,117 2,073 1,620 179.1 42 Jun 12, 2024 J-GAAP
Apr, 2025 27,405 1,786 1,718 1,433 158.2 44 Jun 11, 2025 J-GAAP
Apr, 2026 Guidance 27,700 2,400 2,300 1,600 176.1 49 Mar 11, 2026 J-GAAP
YoY +1.1% +34.4% +33.9% +11.7% +11.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Nov - Jan, 2024 6,738 351 330 331 36.6 5.2 Mar 12, 2025 J-GAAP
Feb - Apr, 2025 6,763 417 406 396 43.7 6.2 Jun 11, 2025 J-GAAP
May - Jul, 2025 6,943 528 503 352 38.9 7.6 Sep 10, 2025 J-GAAP
Aug - Oct, 2025 6,884 682 653 451 49.7 9.9 Dec 10, 2025 J-GAAP
Nov - Jan, 2025 6,966 685 655 471 51.9 9.8 Mar 11, 2026 J-GAAP
YoY +3.4% +95.2% +98.5% +42.3% +42.0%

Related Articles